News and Opinions - World Stem Cell Summit

Artificial cartilage with the help of 3D printing

by admin | Feb 21, 2024 | Bernie Siegel’s WORLD STEM CELL SUMMIT BLOG, News and Opinions

By Tu Wien News A new approach to producing artificial tissue has been developed at TU Wien: Cells are grown in microstructures created in a 3D printer. Is it possible to grow tissue in the laboratory, for example to replace injured cartilage? At TU Wien (Vienna), an...

FDA accepts first AI algorithm to drug development tool pilot, with Deliberate AI’s anxiety and depression assessment

by admin | Feb 20, 2024 | Bernie Siegel’s WORLD STEM CELL SUMMIT BLOG, News and Opinions

By Andrea Park -Fierce Biotech – For the first time since it launched in 2020 and began accepting submissions in 2022, a program started by the FDA to provide support for unconventional drug development tools has accepted its first artificial...

Cell Therapy Shows Promise for Severe Lung Condition in Small Trial

by admin | Feb 16, 2024 | Bernie Siegel’s WORLD STEM CELL SUMMIT BLOG, News and Opinions

by Technology Networks – Biopharma News – Initial trial suggests invariant natural killer cell therapy improves survival. Promising trial results indicate that a new type of cell therapy could improve the prognosis of those who are critically ill with...

Ancient viral DNA plays role in early embryo development

by admin | Feb 15, 2024 | Bernie Siegel’s WORLD STEM CELL SUMMIT BLOG, News and Opinions

By Dr Naomi Phillips – Progress.org – Viral genetic material, integrated into our DNA millions of years ago, has an essential role in a key early stage in embryo development. Using a mouse model, scientists in Spain have shown that endogenous retroviruses,...

Neurona raises 0M to take epilepsy cell therapy to late-stage development

Neurona raises $120M to take epilepsy cell therapy to late-stage development

by admin | Feb 14, 2024 | Bernie Siegel’s WORLD STEM CELL SUMMIT BLOG, News and Opinions

By Kyle LaHucik – Endpoints News Neurona Therapeutics has gathered $120 million in what is expected to be its last private financing round to wrap up an open-label study this year and move its epilepsy cell therapy into a randomized Phase II in 2025, CEO and...

Jennifer Doudna: Delivering the future of CRISPR-based genome editing

by admin | Feb 13, 2024 | Bernie Siegel’s WORLD STEM CELL SUMMIT BLOG, News and Opinions

by Marni Ellery – Berkley Engineering – Nobel laureate details new applications at Kuh Distinguished Lecture. Jennifer Doudna, Nobel laureate and Li Ka Shing Chancellor’s Chair and Professor in the Departments of Chemistry and of Molecular and Cell...